Pfizer asked the U.S. government Thursday to allow use of its COVID-19 vaccine in children ages 5 to 11 in what would be a major expansion that could combat an alarming rise in serious infections in youngsters and help schools stay open. If regulators give the go-ahead, reduced-dose kids’ shots could begin within a matter of weeks for the roughly […]
